Ab­Cellera hopes to restart patent in­fringe­ment law­suits against Berke­ley Lights af­ter US patent of­fice de­nies re­hear­ing

An­ti­body biotech Ab­Cellera de­clared vic­to­ry on Mon­day in a patent fight with bi­ol­o­gy tools com­pa­ny Berke­ley Lights af­ter a US Patent Of­fice ap­peal board de­nied Berke­ley’s re­quest for a re­hear­ing over one of Ab­Cellera’s patents. Now, Ab­cellera hopes to restart a patent law­suit in­fringe­ment case against the com­pa­ny.

The chal­lenged patent cov­ers “mi­croflu­idic de­vices and us­ing such de­vices to cul­ture cells, mon­i­tor a re­sponse, and re­cov­er se­lect­ed cells, an im­por­tant part of Ab­Cellera’s end-to-end mon­o­clon­al an­ti­body de­vel­op­ment en­gine,” ac­cord­ing to Ab­Cellera.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER